
Harnessing innate power: Targeting the root causes of inflammation and fibrosis
By redefining how we target inflammation and fibrosis, Calluna Pharma is paving the way for groundbreaking therapeutics that will change the lives of patients worldwide.
Our mission
Calluna is a global fibrosis and inflammation-focused biotech company driven by a lean, committed team, with first-in-class clinical-stage antibodies in indications of high unmet need and strategic importance. Our innovative approach targets upstream disease amplifiers, applicable across various medical conditions. By redefining how we target fibrosis and inflammation, Calluna Pharma is paving the way for groundbreaking therapeutics that will change the lives of patients worldwide